Two genes that are responsible for inflammatory bowel disease (IBD) in children have been identified by researchers from Children's Hospital of Philadelphia.
The researchers strongly believe that these genes can be added to the list of genes already known to affect IBD, even though further research is needed to identify the specific disease-causing mutations in the new genes.
Anti-cancer Therapies may Be Derived from Marine Animals
A new study suggests that natural products derived from marine animals may have potential use in anti-cancer therapies, and help improve drug delivery.
Advertisement
"As we continue to find genes that interact with each other and with environmental influences in this complex, chronic disease, we are building the foundation for personalized treatments tailored to a patient's genetic profile," Nature magazine quoted co-first author Robert N. Baldassano, director of the Centre for Pediatric Inflammatory Bowel Disease at The Children's Hospital of Philadelphia, as saying.
"We will resequence the gene regions we have identified to pinpoint the causative mutations in these genes," said study leader Hakon Hakonarson, director of the Centre for Applied Genomics at Children's Hospital.
!['Good' Gut Bacteria Linked to Better Outcome in Inflammatory Bowel Disease]( "'Good' Gut Bacteria Linked to Better Outcome in Inflammatory Bowel Disease")
Scientists at the California Institute of Technology have found that a good bacterium in the gut called Bacteroides fragilis produces a sugar molecule that may offer a potential
"We strongly suspect one gene will provide a compelling target for drug development, given what's known about its biology," Hakonarson added.
During the study, the researchers performed a genome-wide association in DNA samples from 1,000 patients with childhood-onset IBD.
They discovered two novel gene variants, one on chromosome 20 and the other on chromosome 21.
They said that the TNFRSF6B gene on chromosome 20 is a compelling candidate, because it is already known to participate in the biological pathway of a protein called tumour necrosis factor (TNF), which plays a key role in the harmful inflammation characteristic of IBD.
The study appears in Nature Genetics.
Source: ANI
RAS/L
'Good' Gut Bacteria Linked to Better Outcome in Inflammatory Bowel Disease
Scientists at the California Institute of Technology have found that a good bacterium in the gut called Bacteroides fragilis produces a sugar molecule that may offer a potential
Advertisement
"We strongly suspect one gene will provide a compelling target for drug development, given what's known about its biology," Hakonarson added.
During the study, the researchers performed a genome-wide association in DNA samples from 1,000 patients with childhood-onset IBD.
They discovered two novel gene variants, one on chromosome 20 and the other on chromosome 21.
They said that the TNFRSF6B gene on chromosome 20 is a compelling candidate, because it is already known to participate in the biological pathway of a protein called tumour necrosis factor (TNF), which plays a key role in the harmful inflammation characteristic of IBD.
The study appears in Nature Genetics.
Source: ANI
RAS/L
Perceptions of Physicians and Patients Differ on the Impact of Colitis
A nationwide survey has revealed that almost three out of four patients with ulcerative colitis (UC) consider that feeling unwell is just a part of life.
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Genetics & Stem Cells News
NGN-401 is a first ever new gene therapy discovered to cure a rare genetic brain disorder called Rett Syndrome.
Among MS patients, the stem cells showed a neuroprotective role, guarding nerve cells from further decline.
New possibilities for research on digestive diseases have been set by complete decoding of the Y chromosome.
UK has given the green light to the world's inaugural gene therapy for sickle-cell disease and thalassemia.
1 in 25 people had a genotype linked to short lifetime, which includes BRCA2 and LDLR genes, that reduced lifespan by seven years, and six years respectively.